Julia Eastland
Chief Executive Officer at HARPOON THERAPEUTICS, INC.
Net worth: 5 907 $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Myers | M | 57 |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | 8 years |
| Ryan Spencer | M | 46 | 19 years | |
| David Novack | M | 62 | 11 years | |
| Francis Cano | M | 79 | 15 years | |
| Peggy Phillips | F | 70 | 18 years | |
| Dan Kisner | M | 77 | 14 years | |
| Peter Paradiso | M | 73 | 4 years | |
| Brent MacGregor | M | 60 | 4 years | |
| Elaine Sun | F | 53 | 3 years | |
| Robert Janssen | M | 70 | 14 years | |
| Meg Smith | F | - | 5 years | |
| Frank Lanza | M | 62 | 5 years | |
| Luke Walker | M | - | 2 years | |
| Rachael Lester | F | - | 7 years | |
| Patricia Novy | M | - | 3 years | |
| David Kabakoff | M | 76 |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | 6 years |
| Alex Oh | M | - | 2 years | |
| Wendy Chang | F | - | 2 years | |
| Banmeet Anand | M | - | 2 years | |
| Chatan Charan | M | - | 2 years | |
| Todd Lopeman | M | - | 10 years | |
| Holger Wesche | M | 56 | 6 years | |
| Riccardo Manetti | M | - | 4 years | |
| Dong Yu | M | - | 3 years | |
| Justin Burgess | M | - | 12 years | |
| Nicole Arndt | F | - | - | |
| Paul Cox | M | - | 1 years | |
| John L. Slebir | M | 58 | 3 years | |
| Jeff P. Coon | M | 61 | 5 years | |
| James B. Bucher | M | 59 | 1 years | |
| Haibo Wang | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Henney | M | 83 | 26 years | |
| Martin Simonetti | M | 66 | 14 years | |
| Reinhard Gabathuler | M | - | 5 years | |
| Mitchell Gold | M | 57 | 12 years | |
| Nancy Whiting | M | 51 | - | |
| Georgia Erbez | F | 57 | 4 years | |
| Madhavan Balachandran | M | 73 | 20 years | |
| Stephen Lau | M | 52 |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | - |
| Andrew Hack | M | 50 | 4 years | |
| Luke Evnin | M | 60 | 5 years | |
| Ron Hunt | M | 59 | 7 years | |
| Richard B. Brewer | M | 72 | - | |
| Patrick Baeuerle | M | 66 | 5 years | |
| Robert L. Kirkman | M | 75 | 9 years | |
| Gerald McMahon | M | 69 | 5 years | |
| John Smither | M | 71 | 6 years | |
| Shashi Karan | M | 70 | 2 years | |
| Jonathan Drachman | M | 62 | 6 years | |
| Douglas Williams | M | 66 | 4 years | |
| Susan B. Bayh | F | 64 | 12 years | |
| Lauren Silvernail | F | 65 | 2 years | |
| Frans Gustaf Wuite | M | 64 | - | |
| H. Shepard | M | 74 | - | |
| Diana Hausman | M | 61 | 7 years | |
| Andrew Robbins | M | 48 | 4 years | |
| Steven James | M | 66 | 3 years | |
| Mark Chin | M | 42 | 7 years | |
| Joanne Viney | M | 58 | 3 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| Alan Colowick | M | 61 | 2 years | |
| W. Vickery Stoughton | M | 78 | 18 years | |
| Ted Love | M | 65 | 5 years | |
| Joseph Bailes | M | 67 | 4 years | |
| Bogdan Dziurzynski | M | 75 | 14 years | |
| Richard L. Jackson | M | 84 | 14 years | |
| Dan Spiegelman | M | 65 | 10 years | |
| David Baltimore | M | 86 | 21 years | |
| Frank Valone | M | 74 | 8 years | |
| Peter García | M | 62 | 14 years | |
| Richard F. Hamm | M | 64 | 7 years | |
| Daniel Flynn | M | 70 | - | |
| Marisa Co | F | - | 10 years | |
| Daniel Vapnek | M | 85 | 15 years | |
| Larry Alan May | M | 74 | 15 years | |
| Margaret E. Valeur-Jensen | M | 67 | 7 years | |
| Brian Blackman | M | - | 4 years | |
| Robert S. Attiyeh | M | 90 | 4 years | |
| Robert N. Purcell | M | 54 | 12 years | |
| Robert Azelby | M | 56 | 1 years | |
| Alex M. DePaoli | M | - | - | |
| William D. Welch | M | - | 5 years | |
| Wen Chen | M | 56 | - | |
| Warren Wayne Myers | M | 62 | 10 years | |
| Carol Gallagher | M | 59 | 8 years | |
| Juan Jaen | M | 66 | 10 years | |
| Gregory Stea | M | 66 | 9 years | |
| Kevin Koch | M | 63 | 3 years | |
| Gwen A. Fyfe | M | 72 | 2 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Danute M. Bankaitis-Davis | M | - | 6 years | |
| Stephen H. Watkins | M | - | 6 years | |
| Mark Nathan Lampert | M | 56 | 1 years | |
| J. Garland | M | 55 | 5 years | |
| Rosemary Mazanet | M | 67 | 5 years | |
| Brian Lian | M | - | 3 years | |
| Pirow Bekker | M | 63 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Julia Eastland
- Personal Network